| Date Filed | Type | Description |
| 08/22/2023 |
4
| Weisenhoff Michael (Assistant Controller) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 4,000 shares
@ $0 |
|
| 08/21/2023 |
4
| Doucot Charles M (Executive Vice President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Sold 12,700 shares
@ $4.66, valued at
$59.2k
|
|
| 08/21/2023 |
4
| Hullinger Brian (President & CEO) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 100,000 options to buy
@ $4.64, valued at
$464k
Granted 200,000 options to buy
@ $4.64, valued at
$928k
|
|
| 08/21/2023 |
4
| Reynolds Andrew (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
4
| Davis Robyn C (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
4
| Kamin Peter (10% Owner) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/21/2023 |
4
| NEVIN DARIUS G (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 14,000 shares
@ $0 |
|
| 08/17/2023 |
3
| Hullinger Brian (President & CEO) has filed a Form 3 on PSYCHEMEDICS CORP |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/24/2023 |
4
| SCHAFFER MICHAEL I (VP of Laboratory Operations) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 375 shares
@ $4.93, valued at
$1.8k
|
|
| 05/24/2023 |
4
| Doucot Charles M (Executive Vice President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 825 shares
@ $4.93, valued at
$4.1k
|
|
| 05/24/2023 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,500 shares
@ $4.93, valued at
$7.4k
|
|
| 05/16/2023 |
4
| Doucot Charles M (Executive Vice President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 900 shares
@ $4.87, valued at
$4.4k
|
|
| 05/16/2023 |
4
| SCHAFFER MICHAEL I (VP of Laboratory Operations) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 337 shares
@ $4.87, valued at
$1.6k
|
|
| 05/16/2023 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,725 shares
@ $4.87, valued at
$8.4k
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/16/2022 |
4
| Kamin Peter (10% Owner) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 9,000 shares
@ $0 |
|
| 08/16/2022 |
4
| NEVIN DARIUS G (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 9,000 shares
@ $0 |
|
| 05/24/2022 |
4
| Davis Robyn C (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 05/24/2022 |
4
| WEINERT FRED J (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 05/24/2022 |
4
| TOMENSON WALTER S (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 05/24/2022 |
4
| Reynolds Andrew (Director) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 12,000 shares
@ $0 |
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| SCHAFFER MICHAEL I (VP of Laboratory Operations) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 05/24/2022 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| SCHAFFER MICHAEL I (VP of Laboratory Operations) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 337 shares
@ $6.44, valued at
$2.2k
|
|
| 05/17/2022 |
4
| KUBACKI RAYMOND C JR (Chairman, CEO & President) has filed a Form 4 on PSYCHEMEDICS CORP|
Txns:
| Paid exercise price by delivering 1,725 shares
@ $6.44, valued at
$11.1k
|
|
|